Adult mouse astrocytes degrade amyloid-β in vitro and in situ

Nature Medicine

Volumn 9, Issue 4, 2003, Pages 453-457

  Wyss Coray, Tony ^a,b   Loike, John D ^c   Brionne, Thomas C ^b   Lu, Emily ^c   Anankov, Roman ^c   Yan, Fengrong ^d   Silverstein, Samuel C ^c   Husemann, Jens ^c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d Glad stone Institute of Neurological Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; CHEMOKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN; BRAIN LEVEL; CELL ADHESION; CELL CULTURE; CELL FUNCTION; CELL MIGRATION; CLEARANCE; CONTROLLED STUDY; DISEASE MODEL; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN IMMOBILIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; CELL MOVEMENT; CHEMOKINE CCL2; MICE; PEPTIDE FRAGMENTS;

ANIMALIA;

EID: 0037394788     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm838     Document Type: Article

References (25)

1. Role of inflammatory processes and microglial activation in Alzheimer's disease. In Alzheimer's Disease (ed. Terry, R.D.) chap. 26, 390 (Lippincott Williams & Wilkins, Philadelphia, Pennsylvania, 1999).
2. Heesen, M. et al. Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor. J. Neurosci. Res. 45, 382-391 (1996).
3. Hayashi, M., Luo, Y., Laning, J., Strieter, R.M. & Dorf, M.E. Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J. Neuroimmunol. 60, 143-150 (1995).
4. Johnstone, M., Gearing, A.J. & Miller, K.M. A central role for astrocytes in the inflammatory response to β-amyloid; chemokines, cytokines and reactive oxygen species are produced. J. Neuroimmunol. 93, 182-193 (1999).
5. Rezaie, P., Trillo-Pazos, G., Everall, I.P. & Male, D.K. Expression of β-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 37, 64-75 (2002).
6. Ishizuka, K. et al. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiat. Clin. Neurosci. 51, 135-138 (1997).
7. Mehlhorn, G., Hollborn, M. & Schliebs, R. Induction of cytokines in glial cells surrounding cortical β-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology. Int. J. Dev. Neurosci. 18, 423-431 (2000).
8. Tezel, G., Hernandez, M.R. & Wax, M.B. In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head. Glia 34, 178-189 (2001).
9. Tawil, N.J. et al. α 1 β 1 integrin heterodimer functions as a dual laminin/collagen receptor in neural cells. Biochemistry 29, 6540-6544 (1990).
10. Husemann, J., Loike, J.D., Anankov, R., Febbraio, M. & Silverstein, S.C. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40, 195-205 (2002).
11. Husemann, J., Loike, J.D., Kodama, T. & Silverstein, S.C. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar β-amyloid. J. Neuroimmunol. 114, 142-150 (2001).
12. Wegiel, J., Wang, K.C., Tarnawski, M. & Lach, B. Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation. Acta Neuropathol. (Berl.) 100, 356-364 (2000).
13. Kurt, M.A., Davies, D.C. & Kidd, M. β-amyloid immunoreactivity in astrocytes in Alzheimer's disease brain biopsies: an electron microscope study. Exp. Neurol. 158, 221-228 (1999).
14. Thal, D.R. et al. Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex. Acta Neuropothol. (Berl.) 100, 608-617 (2000).
15. Yamaguchi, H., Sugihara, S., Ogawa, A., Saido, T.C. & Ihara, Y. Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques. Acta Neuropathol. (Berl.) 95, 217-222 (1998).
16. Shaffer, L.M. et al. Amyloid β protein (A β) removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745 (1995).
17. Wyss-Coray, T. & Mucke, L. Inflammation in neurodegenerative disease - a double edged sword. Neuron 35, 419-432 (2002).
18. DeWitt, D.A., Perry, G., Cohen, M., Doller, C. & Silver, J. Astrocytes regulate microglial phagocytosis of senile plaque cores of Alzheimer's disease. Exp. Neurol. 149, 329-340 (1998).
19. Bard, F. et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916-919 (2000).
20. Savchenko, V.L., McKanna, J.A., Nikonenko, I.R. & Skibo, G.G. Microglia and astrocytes in the adult rat brain: comparative immunocytochemical analysis demonstrates the efficacy of lipocortin 1 immunoreactivity. Neuroscience 96, 195-203 (2000).
21. De Groot, C.J. et al. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: immunophenotypical and functional characterization. J. Neurosci. Res. 49, 342-354 (1997).
22. Coraci, I.S. et al. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to β-amyloid fibrils. Am. J. Pathol. 160, 101-112 (2002).
23. Paresce, D.M., Ghosh, R.N. & Maxfield, F.R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17, 553-565 (1996).
24. Wyss-Coray, T. et al. TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612-618 (2001).
25. 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050-4058 (2000).